Summary. Abstract. Acute pancreatitis remains one of the most prevalent diseases worldwide. Alcoholic and biliary factors are considered the most common causes of AP. The aim of the study was to investigate the laboratory characteristics of patients with AP, taking into account the etiological variant of the disease. Materials and methods: the study is retrospective. Medical records of 677 patients hospitalized for AP in two medical institutions from 2017 to 2022 were analyzed: Vinnytsia сity сlinical emergency hospital and Vinnytsia regional clinical hospital named after M.I. Pyrogov. For further study of laboratory parameters of all AP patients, they were divided into four groups depending on the etiology: alimentary, biliary, alcoholic, and postoperative. The laboratory data obtained within the first 24 hours of hospitalization were analyzed. Results. Intergroup differences in the distribution of laboratory parameters were observed among different etiological variants of AP. Some of them showed only significant intergroup deviations within reference values, while some also deviated from the norm. Specifically, for alimentary AP, there was a significant increase in creatinine levels compared to other groups. For biliary AP, there was a significant increase in leukocyte count, neutrophil-to-lymphocyte ratio, total bilirubin, blood glucose levels, and a significant decrease in lymphocyte count. For postoperative AP, there was a significantly the lowest level of increase of serum amylase levels, significant elevation in ALT and AST levels, and significant increase in stabs neutrophils and ESR compared to other groups. Conclusions. Analysis of blood and urine laboratory parameters in patients with AP allowed to identify intergroup differences in their distribution for different etiological variants of AP without deviation from the norm, as well as deviations from reference values. The obtained data should be taken into account at the stage of hospitalization and the beginning of inpatient treatment of patients with AP for further stratification and development of individualized diagnostic and therapeutic programs.